Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Clasco Cream is a topical corticosteroid formulation containing clobetasol propionate, developed and marketed by Ferozsons Laboratories. Clobetasol propionate is a highly potent (Class I) glucocorticoid used for the treatment of various inflammatory and pruritic skin conditions, such as psoriasis and recalcitrant eczemas. It works by binding to cytoplasmic glucocorticoid receptors, subsequently translocating to the nucleus to modulate gene expression. This action leads to the synthesis of anti-inflammatory proteins (such as lipocortins) and the inhibition of inflammatory mediators like prostaglandins and leukotrienes, effectively reducing skin inflammation, redness, and itching.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on clobetasol propionate.